期刊文献+

低分子量肝素钠的制备与临床应用 被引量:6

Progress in preparation and clinical applications of low molecular weight heparin
下载PDF
导出
摘要 低分子肝素有抗凝血、抗血栓、调血脂、抗肿瘤等作用,与普通肝素相比具有皮下注射吸收好、半衰期长、生物利用率高,与血浆、血小板亲和力小、出血副作用少等优点。对低分子肝素的制备、质量检测和临床应用的研究进展进行了综述。 Low molecular weight heparin(LMWH) posseses a lot of physiologic activity,including anticoagulatlon,resistance to thrombus formation and cancer,regulation of blood ester.As compared with unfractionated heparin,it has advantages such as better absorption by subcutaneous injection,longer half life,higher utilization,lower affinity to plasm and blood platelet,less hemorrhage.The progres about preparation methods,quality assay and clinical application of LMWH are introduced and reviewed.
作者 韦传宝
出处 《生物学杂志》 CAS CSCD 2006年第6期35-37,共3页 Journal of Biology
基金 安徽省教育厅自然科学研究项目(2006KJ415B)
关键词 低分子肝素 制备方法 临床应用 研究进展 low molecular weight heparin preparation methods clinical application progress
  • 相关文献

参考文献13

二级参考文献55

  • 1陈淑慧,张淑敏,刘建平.低分子肝素治疗进展型脑梗死的临床观察[J].中国综合临床,2004,20(8):679-680. 被引量:1
  • 2李发成,崔磊,孙欲晓,钱云良,陈诗书,关文祥.腺病毒载体介导人VEGF cDNA促进随意型皮瓣成活的实验研究[J].中华整形外科杂志,2004,20(6):434-438. 被引量:4
  • 3Frisc Study Group. Low - molecular - weight hearin during instability in coronary artery disease, Fragmin during Instability in Coronary Artery Disease (FRISC) study group. Lancet, 1996, (347):561.
  • 4Husted SE, Wallentin L, Lagerqvist B, et al. Benefits of extended treatment with dalteparin in patients with unstable coronary artery disease eligible for revascularization. Eur Heart J,2002 23(15):1213.
  • 5Cosmi B,Hirsh J. Low molecular weight heparins. Curr Opin Cardiol , 1994,9 (2) :612.
  • 6Seiumbata T, Caretto P, Pirovano P, et al.Treatment with modified heparins experimental metastasis formation and leads,in some animals, to long-term survival[ J ].Invasion Metastasis,996,16(3) :132-143.
  • 7Loynes JT, Zacharski LR, Rigos JR. Regression of metastatic non-small cell lung cancer with low molecular weight heparin[J]. Thromb Haemost,2002,88(4) : 686.
  • 8Hejna M, Raderer M, Zielinski CC. Inhibition of metastases by anticoagulants[ J ]. J Natl Cancer Inst, 1999,91 ( 1 ) : 22-36.
  • 9Rickles FR, Levine MN, Edwards RL. Hemostic alternation in cancer patients[J]. Cancer Met Rev,1992,11 : 237-248.
  • 10Goad KE, Gralnick HR. Coagulation disorders in cancer[ J ].Hematol Oncol Clin North Am,1996,10: 457-484.

共引文献130

同被引文献49

引证文献6

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部